July 24, 2014

FDA Announces New Rules for OTC Sunscreen Products

The FDA recently announced new requirements for sunscreens sold over-the-counter. The new rules came in the form of a Final Rule,  a Proposed Rule, an Advance Notice of Proposed Rulemaking, and a Draft Guidance for Industry.

The Final Rule, which will be effective in the summer of 2012, addresses the labeling of sunscreens with Sun Protection Factor (SPF) ratings. Currently, SPF ratings relate only to protection against sunburn caused by ultraviolet (UV) B rays  and not to protection against skin cancer and premature skin aging caused by UVA rays. The Final Rule establishes a Broad Spectrum SPF rating which covers both UVA and UVB protection. Sunscreens that pass FDA’s broad spectrum test procedure may be labeled as “Broad Spectrum SPF [value].” Further, sunscreens with a Broad Spectrum SPF value of 15 or more can claim to reduce the risk of skin cancer and early skin aging when used as directed and with other skin protection measures. The other skin protection measures include wearing protective clothing and limiting exposure to the sun. Conversely, sunscreens with a Broad Spectrum SPF value of 2-14, or which do not pass the broad spectrum test, can only claim to prevent sunburn. These rules apply to all cosmetics and moisturizers that claim to provide Broad Spectrum SPF protection.

The Final Rule also prohibits manufacturers  from labeling sunscreens as “waterproof” or “sweatproof” or as “sunblocks.” Further, without prior FDA approval, manufacturers cannot claim that their sunscreens provide “immediate” protection or that they provide protection for more than two hours without reapplication. Claims of “water resistance” must state whether the sunscreen remains effective for 40 or 80 minutes while swimming or sweating, based  on standard testing. Sunscreens that are not water resistant must include an instruction to consumers to use a water resistant sunscreen if swimming  or sweating. Finally, all sunscreens must include standard “Drug Facts” information.

The Proposed Rule would limit the maximum SPF value on sunscreen labels to 50+. According to the FDA, there is insufficient evidence that products with SPF values higher than 50 provide greater protection for users. 

By the Advance Notice of Proposed Rulemaking, the FDA is seeking additional data on the safety and effectiveness of sunscreen products in different dosage forms, such as lotions, oils, sticks, gels, butters, ointment, creams and pastes. Prior rules have not specified to which dosage forms the regulations apply, and the FDA is seeking evidence upon which to base such a decision.

Although the Final Rule does not become effective until the summer of 2012, consumers can
already see the new labeling as manufacturers take advantage of the use claims. 

This Barnes & Thornburg LLP publication should not be construed as legal advice or legal opinion on any specific facts or circumstances. The contents are intended for general informational purposes only, and you are urged to consult your own lawyer on any specific legal questions you may have concerning your situation. 


About the Author

Lynn C. Tyler, M.S, Barnes Thornburg Law Firm, Patent Attorney

Lynn C. Tyler is a partner and registered patent lawyer in the firm’s Intellectual Property Department. Mr. Tyler helps innovative companies secure and preserve their market position and competitive advantage by navigating their way through the FDA to the marketplace and enforcing their intellectual property rights, which often must be protected against imitators who seek to reap where they have not sown. He litigates intellectual property matters and represents clients at virtually all stages of the process, including pre-litigation counseling, alternative dispute resolution, formal...


Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is  intended to be  a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.

The National Law Review - National Law Forum LLC 4700 Gilbert Ave. Suite 47 #230 Western Springs, IL 60558  Telephone  (708) 357-3317 If you would ike to contact us via email please click here.